▮ Event HighlightsView All
Now in its 6th consecutive year, Scientific American Worldview: A Global Biotechnology Perspective will have its official launch in a special Super Session at the BIO International Convention today at 2pm. Moderated by television and radio personality David Brancaccio (Marketplace Morning; PBS Now) this exciting event will explore the ever-globalized ethos of life science innovation and examine the many multicultural elements driving new partnerships, new products and new paradigms.
▮ Business Development/FinanceView All
What is all the excitement about ? “Bioeconomy” refers to all economic activity that is derived from the commercial application of biotechnology. It encompasses the production of renewable biological resources and their conversion into food, feed, chemicals, energy and healthcare wellness products via innovative and efficient technologies.
▮ Health CareView All
Prostate cancer is the second leading cause of cancer death in American men, behind lung cancer. According to the American Cancer Society, around 230,000 new cases of prostate cancer are diagnosed and 30,000 men die from the disease each year. Cancer immunotherapy offers one promising approach to combating the disease. The University of California, San Francisco, (UCSF) and biotechnology company Advaxis are partnering to evaluate a number of promising immunotherapy constructs.
▮ InternationalView All
Innovation is not just the life-blood of the biotech industry, it is the very premise of the BIO International Convention. So what is a panel on international trade doing here? Answering this question is the task panel moderator, Richard Bergstrom, Director General, EFPIA gave to participants in the session TTIP: Can US and the EU Lead the Way in Setting New Global Benchmarks for IP, Regulatory and Market Access Issues; and each provided a piece of the answer...